Viewing Study NCT05240404


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2025-12-25 @ 7:01 PM
Study NCT ID: NCT05240404
Status: UNKNOWN
Last Update Posted: 2022-02-15
First Post: 2022-02-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma
Sponsor: Xiangya Hospital of Central South University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module